For example, it was recently shown that monoclonal antibody blockade of IL-33 in mice xenografted with human non-small-cell lung carcinoma (NSCLC) decreased the accumulation of TREG cells and reduced macrophage M2 polarization, leading to the efficient inhibition of tumor growth (158). This evidence concerns the gene IL33 and neoplasm.